PetIQ, Inc. (PETQ) |
| 30.98 -0.01 (-0.03%) 10-24 16:00 |
| Open: | 30.99 |
| High: | 31 |
| Low: | 30.98 |
| Volume: | 928,270 |
| Market Cap: | 919(M) |
| PE Ratio: | 83.73 |
| Exchange: | NASDAQ Global Select |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 84.93 |
| Resistance 1: | 69.79 |
| Pivot price: | 55.24 |
| Support 1: | 45.31 |
| Support 2: | 37.69 |
| 52w High: | 31.06 |
| 52w Low: | 15.09 |
PetIQ, Inc. operates as a prominent enterprise in the pet health and wellness sector, with a market presence across the United States and internationally. Its operations are strategically divided into two primary segments: Products and Services. Within its Products division, the company provides a comprehensive range of veterinary prescription medications. This includes crucial treatments for issues like flea and tick control, heartworm prevention, arthritis, thyroid disorders, diabetes management, pain relief, various antibiotics, and other specialized pharmaceuticals. PetIQ is unique in that it both develops and manufactures its own line of exclusive, value-branded products, while also serving as a distributor for numerous established third-party branded medications. Furthermore, it supplies over-the-counter (OTC) medications and related supplies, with a strong emphasis on flea and tick control and behavior management solutions. These OTC offerings are available in diverse formats, such as topical spot-on applications, chewable and oral tablets, and collars. Beyond medications, the company also features health and wellness products, including specialized dental treats and a variety of nutritional supplements for concerns like hip and joint health, general vitamins, and improvements to skin and coat. This extensive product portfolio is marketed under a wide array of brand names, including PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles. The Services segment delivers an extensive suite of veterinary care options. PetIQ manages approximately 2,900 community clinics and wellness centers, frequently hosted within pet retail locations across 42 states. These centers provide essential services such as diagnostic testing, comprehensive vaccination programs, dispensing of prescription medications, microchipping, and routine wellness examinations. With an impressive reach, PetIQ leverages approximately 60,000 distribution points, ensuring its products and services are readily available through diverse channels, including veterinary practices, traditional retail stores, and online e-commerce platforms. Established in 2010, PetIQ, Inc. is headquartered in Eagle, Idaho.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Thu, 21 May 2026
PetIQ stock (US71639T1060): cash merger closes and trading ends for pet health provider - AD HOC NEWS
Thu, 24 Apr 2025
PETQ Stock Price, News & Analysis | Petiq - Stock Titan
Tue, 11 Feb 2025
PETQ Leadership Coup: Coty's Former CEO Takes Helm at PetIQ - Strategic Growth Move Signals Major Transformation - Stock Titan
Fri, 25 Oct 2024
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group - Yahoo Finance
Fri, 09 Aug 2024
petq-20240630 - SEC.gov
Wed, 07 Aug 2024
PetIQ Inc Reports Q2 2024 Earnings: EPS of $0.49, Revenue at $32 - GuruFocus
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |